Literature DB >> 18180325

Molecular cloning and pharmacological characterization of porcine melanocortin-3 receptor.

Zhen-Chuan Fan1, James L Sartin, Ya-Xiong Tao.   

Abstract

Mouse gene targeting studies revealed that the melanocortin-3 receptor (MC3R) affected feeding efficiency and fat storage in mice. The functions of the MC3R in other mammalian species remain to be investigated. We are interested in exploring the functions of the porcine MC3R (pMC3R) in regulating fat storage because of the economical importance of swine industry. Although nucleotide sequences of MC3Rs from several species have been reported, pMC3R had not been cloned and sequenced. We reported herein the molecular cloning and pharmacological analysis of the pMC3R. Sequence analysis revealed that pMC3R was highly homologous (>80%) at nucleotide and amino acid sequences to human, rat, and mouse MC3Rs. With human MC3R (hMC3R) as a control, the binding and signaling properties of pMC3R were investigated using several agonists including alpha- and gamma-melanocyte-stimulating hormone (alpha- and gamma-MSH), D-Trp(8)-gamma-MSH, and [Nle(4)-D-Phe(7)]-MSH (NDP-MSH) and the natural antagonist agouti-related protein (AgRP). The results showed that pMC3R bound NDP-MSH with the highest affinity followed by D-Trp(8)-gammaMSH, gamma-, and alpha-MSH. The same ranking was also found for hMC3R, although pMC3R had two- to ninefold higher affinities for these ligands. Both pMC3R and hMC3R bound AgRP with high affinity. D-Trp(8)-gamma-MSH was the most potent agonist to stimulate cAMP generation followed by NDP-, alpha-, and gamma-MSH. This ranking was the same as that of hMC3R. The availability of pMC3R and its pharmacological characteristics will facilitate the investigation of pMC3R in regulating food intake and fat storage.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18180325     DOI: 10.1677/JOE-07-0403

Source DB:  PubMed          Journal:  J Endocrinol        ISSN: 0022-0795            Impact factor:   4.286


  9 in total

1.  Functional studies on twenty novel naturally occurring melanocortin-4 receptor mutations.

Authors:  Zhi-Qiang Wang; Ya-Xiong Tao
Journal:  Biochim Biophys Acta       Date:  2011-06-30

2.  Pharmacological characterization of canine melancortin-4 receptor and its natural variant V213F.

Authors:  J Yan; Y-X Tao
Journal:  Domest Anim Endocrinol       Date:  2011-06-12       Impact factor: 2.290

3.  The melanocortin-4 receptor: physiology, pharmacology, and pathophysiology.

Authors:  Ya-Xiong Tao
Journal:  Endocr Rev       Date:  2010-02-26       Impact factor: 19.871

4.  Functional characterization of melanocortin-3 receptor in rainbow trout (Oncorhynchus mykiss).

Authors:  Hui-Xia Yu; Yang Li; Wei-Jia Song; Hui Wang; Hao-Lin Mo; Qiao Liu; Xin-Miao Zhang; Ze-Bin Jiang; Li-Xin Wang
Journal:  Fish Physiol Biochem       Date:  2022-01-31       Impact factor: 2.794

5.  Functional characterization of nine novel naturally occurring human melanocortin-3 receptor mutations.

Authors:  Fan Yang; Ya-Xiong Tao
Journal:  Biochim Biophys Acta       Date:  2012-08-03

6.  Functions of acidic transmembrane residues in human melanocortin-3 receptor binding and activation.

Authors:  Shu-Xiu Wang; Zhen-Chuan Fan; Ya-Xiong Tao
Journal:  Biochem Pharmacol       Date:  2008-07-09       Impact factor: 5.858

7.  Biased signaling in naturally occurring mutations in human melanocortin-3 receptor gene.

Authors:  Fan Yang; Hui Huang; Ya-Xiong Tao
Journal:  Int J Biol Sci       Date:  2015-02-23       Impact factor: 6.580

8.  Functional Characterization of Melanocortin-3 Receptor in a Hibernating Cavefish Onychostoma macrolepis.

Authors:  Lian Wu; Huixia Yu; Haolin Mo; Xianyong Lan; Chuanying Pan; Lixin Wang; Haiyu Zhao; Jishu Zhou; Yang Li
Journal:  Animals (Basel)       Date:  2021-12-25       Impact factor: 2.752

9.  Functional characterization and pharmacological rescue of melanocortin-4 receptor mutations identified from obese patients.

Authors:  Zhen-Chuan Fan; Ya-Xiong Tao
Journal:  J Cell Mol Med       Date:  2009-02-27       Impact factor: 5.310

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.